Pelthos Therapeutics Inc.
PTHS
$26.90
$0.602.28%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -420.22% | -1,024.82% | -857.97% | -94.68% | 23.19% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 107.45% | -100.00% | -99.04% | -- | -84.48% |
| Total Other Non-Cash Items | -556.38% | 3,373.96% | 3,052.56% | -9.91% | 66.10% |
| Change in Net Operating Assets | -422.09% | -748.77% | -472.13% | 247.80% | 330.70% |
| Cash from Operations | -1,976.90% | -833.13% | -8,486.78% | 84.86% | 68.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 11,634.80% | 11,722.08% | 107.58% | -76.37% | -- |
| Total Debt Repaid | -- | -- | -422,400.00% | -- | -- |
| Issuance of Common Stock | -- | 45.78% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,909.20% | 25,126.39% | 2,846.09% | -76.37% | -95.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,818.06% | 608.09% | 1,334.61% | 94.72% | -110.40% |